Charles Schwab
NPTN

Charles Schwab’s NEOPHOTONICS CORP NPTN Stock Holding History

Charles Schwab’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-136,196
Closed -$2.14M – 3591
2022
Q2 		$2.14M Sell
136,196
-56
-0% -$855 ﹤0.01% 2554
2022
Q1 		$2.07M Buy
136,252
+976
+0.7% +$14.9K ﹤0.01% 2636
2021
Q4 		$2.08M Buy
135,276
+3,449
+3% +$45.4K ﹤0.01% 2694
2021
Q3 		$1.15M Sell
131,827
-218,389
-62% -$1.99M ﹤0.01% 2823
2021
Q2 		$3.58M Sell
350,216
-50,079
-13% -$529K ﹤0.01% 2512
2021
Q1 		$4.78M Sell
400,295
-27,291
-6% -$309K ﹤0.01% 2321
2020
Q4 		$3.89M Sell
427,586
-134,613
-24% -$1.04M ﹤0.01% 2343
2020
Q3 		$3.42M Buy
562,199
+134,029
+31% +$1.02M ﹤0.01% 2257
2020
Q2 		$3.8M Buy
428,170
+97,102
+29% +$837K ﹤0.01% 2156
2020
Q1 		$2.4M Sell
331,068
-221,513
-40% -$1.64M ﹤0.01% 2199
2019
Q4 		$4.87M Sell
552,581
-6,278
-1% -$47K ﹤0.01% 2027
2019
Q3 		$3.4M Sell
558,859
-91,647
-14% -$515K ﹤0.01% 2163
2019
Q2 		$2.72M Buy
650,506
+171,154
+36% +$902K ﹤0.01% 2262
2019
Q1 		$3.02M Buy
479,352
+288,605
+151% +$2.02M ﹤0.01% 2217
2018
Q4 		$1.24M Buy
190,747
+14
+0% +$107 ﹤0.01% 2477
2018
Q3 		$1.58M Buy
190,733
+7,197
+4% +$54.7K ﹤0.01% 2494
2018
Q2 		$1.14M Buy
183,536
+44,922
+32% +$286K ﹤0.01% 2551
2018
Q1 		$950K Buy
138,614
+4,680
+3% +$29.7K ﹤0.01% 2533
2017
Q4 		$882K Sell
133,934
-16,660
-11% -$102K ﹤0.01% 2546
2017
Q3 		$838K Buy
150,594
+36,050
+31% +$243K ﹤0.01% 2555
2017
Q2 		$885K Buy
114,544
+722
+0.6% +$6.1K ﹤0.01% 2495
2017
Q1 		$1.03M Buy
113,822
+6,498
+6% +$67.7K ﹤0.01% 2415
2016
Q4 		$1.16M Buy
107,324
+5,852
+6% +$78K ﹤0.01% 2381
2016
Q3 		$1.66M Buy
101,472
+59,609
+142% +$839K ﹤0.01% 2224
2016
Q2 		$399K Hold
41,863
– – ﹤0.01% 2673
2016
Q1 		$588K Sell
41,863
-20,423
-33% -$211K ﹤0.01% 2524
2015
Q4 		$677K Hold
62,286
– – ﹤0.01% 2519
2015
Q3 		$425K Buy
62,286
+23,023
+59% +$178K ﹤0.01% 2682
2015
Q2 		$359K Buy
+39,263
New +$298K ﹤0.01% 2802
2014
Q2 		– Sell
-26,800
Closed -$213K – 3155
2014
Q1 		$213K Hold
26,800
– – ﹤0.01% 2927
2013
Q4 		$190K Hold
26,800
– – ﹤0.01% 2965
2013
Q3 		$192K Hold
26,800
– – ﹤0.01% 2930
2013
Q2 		$237K Buy
+26,800
New +$172K ﹤0.01% 2829

Other funds holding NPTN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Charles Schwab's NPTN Position: Q3 2022 in Review

Charles Schwab sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 136,196 shares — an estimated $2.14M sold.

Charles Schwab first reported a position in NPTN in Q2 2013 and held it in 33 quarters. The position peaked at $4.87M in Q4 2019. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

  • Charles Schwab reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
  • Charles Schwab sold 136,196 NEOPHOTONICS CORP shares in Q3 2022, an estimated $2.14M.
  • Charles Schwab first reported a position in NEOPHOTONICS CORP in Q2 2013 and held it in 33 quarters.
  • Charles Schwab's NEOPHOTONICS CORP position peaked at $4.87M in Q4 2019.
  • 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on Charles Schwab's 13F filing for Q3 2022, filed 14 Nov 2022.